News details
Information title
ProteoStasis secures $45M in first round
Published on Monday 25 August 2008 - 17:00 Summary :
Despite a lack of office space or even a complete research team, newcomer ProteoStasis Therapeutics has secured a whopping $45 million in Series A financing. Investors include Boston-based...
Read more
http://www.fiercebiotech.com/news/frontpage
Website description
Get the latest news on the biotech industry, biotech companies, FDA approval and clinical research. Sign up today for the biotech industry
